Information of Publisher
American Journal of Translational Medicine (ISSN 2474 -7378 for print, ISSN 2474-7386 for online) is a peer-reviewed biomedical journal published by Hawaii Gangze Inc in Honolulu, Hawaii, USA, since 2017. The Publisher's website is www.shgangze.com. The Journal's webpage link is below: https://ajtm.journals.publicknowledgeproject.org
Aims & scope
American Journal of Translational Medicine (ISSN 2474 -7378 for print, ISSN 2474-7386 for online) is a peer-reviewed biomedical journal publishing articles focusing on information derived from human experimentation so as to optimize the communication between basic and clinical science.
The journal covers all areas of translational medicine but also has several special sections:
- Artificial Intelligence (AI) and health
- Cancer microenvironment
- Cardiovascular, Metabolic and Lipoprotein Translation
- Cell, Tissue and Gene therapy
- Child health
- Clinical Translation
- Disease biomarkers
- Infectious disease including COVID-19
- Immunobiology and Immunotherapy
- Medical Bioinformatics
- Nutrition and metabolism
- Patient-targeted molecular therapies
- Reproduction and health
- Stem cell therapy
- Tissue engineering and regenerative medicine
Currently, the journal will not provide Open access service, but it may be available for part of article in 2021 or later. This journal will go to the style of Hybrid open access journal since 2021. A hybrid open access journal is a subscription journal in which some of the articles are open access. This status typically requires the payment of a publication fee (also called an article processing charge (APC) or open-assessing fee (OA fee) to the publisher.
American Journal of Translational Medicine may charge $50 as Article-processing fee at this stage (2021).
We would waive this charge for the authors from the institute in India and/or Pakistan in 2021
American Journal of Translational Medicine charges publication fee at $750 per article in 2021 in black and white pages. The color figure (page) is charged additionally $150 per figure (page).
We would waive this charge for the authors from the Instittue in India and/or Pakistan in 2021
The bibliographic databases that index articles published in American Journal of Translational Medicine include:
- Google Scholar
At this stage (2021), We are applying for Pubmed Index for this journal.
American Journal of Translational Medicine is expected to be tracked by Thomson Reuters (ISI) (We have filed application for Inclusion of Index on 2020) and hopefully has an Impact Factor in 2021 or 2022
Publication and peer review process
The peer review process has three types: open, single blind, or double blind. Our AJTM journal take single blind type. The peer-review process normally will take 3 or 4 weeks after submission
The manuscripts will be reviewed by two experts in the similar field. If two reviewers’ recommendation about acceptance is controversial, the editor-in-chief will ask third reviewer to read the manuscript and offer the recommendation. If Editor is familiar with the research field of that manuscript, he/she may review the paper directly and make recommendation, and decision about acceptance.
After review, the paper can be asked for major revision or minor revision exempt direct acceptance.
High-quality, bound reprints can be purchased for all articles published. They can be ordered after the manuscript has been accepted for publication
American Journal of Translational Medicine will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online in journal website and can also be produced in print. For further information, please contact us by email to email@example.com
All manuscripts submitted to American Journal of Translational Medicine should adhere to Hawaii Gangze Inc., Publisher's editorial policies.
Why publish your article in American Journal of Translational Medicine?
- High visibility
American Journal of Translational Medicine's publishing policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a " highly assessed" graphic, which appears on the journal's contents pages and search results.
- Speed of publication
American Journal of Translational Medicine offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through American Journal of Translational Medicine.
Online publication in American Journal of Translational Medicine gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (to sequence and other databases, and to other articles).
- Promotion and press coverage
Articles published in American Journal of Translational Medicine are included in article alerts, and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on American Journal of Translational Medicine's pages and on the Hawaii Gangze Inc., Publisher homepage.
In addition, articles published in American journal of Translational Medicine may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in American Journal of Translational Medicine.
- Plagiarism Policy
Plagiarism is the unethical act of copying someone else’s prior ideas, processes, results or words without explicit acknowledgement of the original author and source. Self-plagiarism occurs when an author utilizes large part of his/her own previously published work without using appropriate references. This can range from getting the same manuscript published in multiple journals to modifying a previously published manuscript with some new data.
In no case shall a journal and members of the editorial board and international scientific committee encourage misconduct of any kind or knowingly allow such misconduct to take place. Members of the editorial board and international scientific committee shall try to prevent misconduct by informing authors and reviewers about the ethical conduct required of them. Members of the editorial board, scientific committee, and reviewers are asked to be aware of all types of misconduct in order to identify papers where research misconduct of any kind has or seems to have occurred and deal with the allegations accordingly.
All manuscripts submitted for publication to journal are cross-checked for plagiarism using Turnitin software. Manuscripts found to be plagiarized during initial stages of review are out-rightly rejected and not considered for publication in the journal. In case a manuscript is found to be plagiarized after publication, the Editorial Board will conduct preliminary investigation, may be with the help of a suitable committee constituted for the purpose. A determination of misconduct will lead journal to run a statement bi-directional linked online to and from the original paper, to note the plagiarism and provide a reference to the plagiarized material. The paper containing the plagiarism will also be marked on each page of the PDF. Upon determination of the extent of plagiarism, the paper may also be formally retracted.
Policy and Action for Plagiarism:
Journal respects intellectual property and aims at protecting and promoting original work of its authors. Manuscripts containing plagiarized material are against the standards of quality, research and innovation. Hence, all authors submitting articles to journal are expected to abide ethical standards and abstain from plagiarism, in any form. In case, an author is found to be suspected of plagiarism in a submitted or published manuscript then, journal shall contact the author (s) to submit his / her (their) explanation within two weeks, which may be forwarded to the Fact Finding Committee (FFC) constituted for the purpose, for further course of action.
Upon having established that the manuscript is plagiarized from some previously published work, Journal shall support the original author and manuscript irrespective of the publisher and may take any or all of the following immediate actions or follow the additional course of actions as recommended by the committee:
- Journal shall remove the PDF copy of the published manuscript from the website and disable all links to full text article. The term Plagiarized Manuscript shall be appended to the published manuscript title.
- Journal shall disable the author account with the journal and reject all future submissions from the author for a period of 03 / 05 / 10 years or even ban the authors permanently.
- Journal may also display the list of such authors along with their full contact details on the journal website.
- Any other course of action, as recommended by the Committee or as deemed fit for the instant case or as decided by the editorial board from time to time.
Authors of articles published in American Journal of Translational Medicine need to transfer the copyright of their articles to Hawaii Gangze Inc, Publisher (for further details, see the Hawaii Gangze Inc., Publisher Copyright and License Agreement
Website of Journal
Publication Ethical statement